Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ZEAL - Zealand Pharma A/S. - ADR

Close
17.59
0.210   1.194%

Share volume: 0
Last Updated: Thu 29 Sep 2022 10:00:00 PM CEST
Pharmaceutical Preparation Manufacturing : -2.88%

PREVIOUS CLOSE
CHG
CHG%
$17.38
0.21
1.21%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
12%
Profitability 0%
Dept financing 6%
Liquidity 73%
Performance 10%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$17.59
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$0.00 - $0.00
52 WEEK CHANGE
$0.00
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
46.538 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$0
AVERAGE 30 VOLUME 
$0
Company detail
CEO: Emmanuel Dulac
Region: US
Website: https://www.zealandpharma.com/
Employees: 329
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Pharmaceutical Preparation Manufacturing
Sector: Manufacturing

Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The head office is situated in Søborg near Copenhagen

Recent news